The role of inherited genetic variants in colorectal polyposis syndromes

• Published in: Advances in genetics Vol. 103; pp. 183 - 217
• Main Authors: Short, E, Sampson, J
• Format: Journal Article
• Language: English
• Published: United States 2019
• Subjects: MSH3-associated polyposis; MUTYH-associated polyposis; Polymerase proofreading associated polyposis; Hyperplastic polyps; Familial adenomatous polyposis; NTHL1-associated polyposis; Colorectal cancer; Adenomas; Hamartomatous polyps; Colorectal polyposis
• ISSN: 0065-2660
• DOI: 10.1016/bs.adgen.2018.11.002

Colorectal carcinoma (CRC) is the third most common cancer in men and the second most common cancer in women across the world. Most CRCs occur sporadically, but in 15-35% of cases, hereditary factors are important. Some patients with an inherited predisposition to CRC will be diagnosed with a "genetic polyposis syndrome" such as familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), polymerase proofreading associated polyposis (PPAP), NTHL1-associated polyposis, MSH3-associated polyposis or a hamartomatous polyposis syndrome. Individuals with ≥10 colorectal polyps have traditionally been referred for genetic diagnostic testing to identify APC and MUTYH mutations which cause FAP and MAP respectively. Mutations are found in most patients with >100 adenomas but in only a minority of those with 10-100 adenomas. The reasons that diagnostic laboratories are not identifying pathogenic variants include mutations occurring outside of the open reading frames of genes, individuals exhibiting generalized mosaicism and the involvement of additional genes. It is important to identify patients with an inherited polyposis syndrome, and to define the mutations causing their polyposis, so that the individuals and their relatives can be managed appropriately.